+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Japan Pet Diagnostics Market, By Offerings, By Technique, By Application, By Pet Type, By End User: By Region - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2024-2032.

  • PDF Icon

    Report

  • 146 Pages
  • July 2024
  • Region: Japan
  • Astute Analytica
  • ID: 5995329
Pet Diagnostics Market, By Offerings (Instruments and Services), By Technique (Diagnostic Imaging, Clinical Biochemistry, Molecular Diagnostics, Immunodiagnostics, Haematology and Others (Histopathology, Cytology), By Application (Clinical Pathology, Pathology, Molecular Diagnostics, Immunodiagnostics and Others), By Pet Type (Dogs, Cats, Horses and Other Pet Animals), By End User (Veterinary Clinics, Veterinary Hospitals, Research Laboratories, Home Care Settings and Diagnostics Centres): By Region - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2024-2032.

Japan Pet Diagnostics Market Forecast till 2032: Set to Reach US$ 0.30 Billion by 2032 with a CAGR of 6.78%

Market Introduction:

The Japan Pet Diagnostics Market is experiencing robust expansion, valued at US$ 0.17 Billion in 2023 and projected to grow at a CAGR of 6.78% from 2024 to 2032

The pet diagnostics market in Japan has witnessed substantial growth, driven by the increasing pet ownership and the heightened awareness among pet owners regarding animal health. As a country that values technological advancements and innovation, Japan has seen the integration of sophisticated diagnostic tools and techniques in veterinary practices. These advancements include molecular diagnostics, imaging technologies such as MRI and CT scans, and advanced laboratory tests, which have significantly enhanced the ability to diagnose and treat various pet ailments effectively.

In Japan, the pet population, especially cats and dogs, has been steadily rising, with a notable shift towards pets being regarded as family members. This cultural shift has spurred a greater demand for comprehensive healthcare services for pets, paralleling those available for humans. Veterinary clinics and animal hospitals across the country are increasingly equipped with state-of-the-art diagnostic equipment, enabling early and accurate detection of diseases, which is crucial for effective treatment and improving the quality of life of pets.

Moreover, the aging pet population in Japan further accentuates the need for advanced diagnostic services, as older pets are more susceptible to chronic conditions that require regular monitoring and specialized care. The Japanese pet diagnostics market is thus poised for continued growth, driven by technological innovation, increasing pet healthcare awareness, and the evolving role of pets in society.

Growth Influencers:

The pet diagnostics market in Japan is experiencing robust growth, driven by a combination of cultural attitudes towards pet care, significant investments in advanced veterinary practices, and technological innovations. Japanese pet owners exhibit a deep-seated dedication to their pets' well-being, reflected in substantial expenditures on healthcare and other essential pet-related services. The nation's pet industry, including healthcare, surpassed $14.7 billion USD in spending in 2023, highlighting the financial commitment to ensuring pets' health and happiness.

One of the key factors propelling this growth is Japan's cultural inclination towards preventive healthcare for pets. Pets are increasingly viewed as integral family members, leading to a proactive approach to veterinary care that includes regular health screenings and early disease detection. This cultural shift is underscored by the high pet ownership rates, with millions of dogs and cats residing in Japanese homes. As such, there is a growing demand for state-of-the-art diagnostic technologies, such as MRI and CT scanners, which are widely adopted in veterinary clinics across major cities like Tokyo and Osaka. These technologies enable precise imaging and early identification of various health conditions, thereby enhancing treatment outcomes and overall quality of life for companion animals.

Technological advancements in veterinary diagnostics play a pivotal role in meeting the escalating demand for advanced healthcare services. Veterinary clinics in Japan are investing in sophisticated equipment that not only improves diagnostic accuracy but also supports comprehensive care strategies. This commitment to innovation is further bolstered by supportive government policies and regulatory frameworks that promote high animal welfare standards and encourage continuous improvement in veterinary practices.

Furthermore, Japan's leadership in veterinary healthcare innovation sets a global benchmark, emphasizing the nation's dedication to advancing animal welfare through cutting-edge diagnostic solutions and comprehensive care approaches. The combination of cultural attitudes, substantial financial investment, technological progress, and supportive policies creates a fertile ground for the continued expansion of the pet diagnostics market in Japan. As the pet population grows and pet owners continue to prioritize their companions' health, the market is poised to further flourish, driving innovation and excellence in veterinary healthcare across the country.

Segment Overview:

The Pet Diagnostics market is categorized based on Offerings, Technique, Application, Pet Type and End User.

By Offerings

  • Instruments
  • Analysers
  • Imaging Equipment's
  • Hematology Instruments
  • Others
  • Consumables
  • Reagents
  • Test Kits
  • Strips
  • Others
  • Services

By Technique

  • Diagnostic Imaging
  • X-ray
  • Ultrasound
  • MRI
  • CT scan
  • Clinical Biochemistry
  • Blood tests
  • Urinalysis
  • Molecular Diagnostics
  • PCR
  • Microarrays
  • DNA Tests
  • Immunodiagnostics
  • ELISA
  • Rapid tests
  • Antibody Tests
  • Haematology
  • Others (Histopathology, Cytology)

By Application

  • Clinical Pathology
  • Haematology
  • Clinical chemistry
  • Immunodiagnostics
  • Pathology
  • Histopathology
  • Cytology
  • Molecular Diagnostics
  • Infectious diseases
  • Genetic disorders
  • DNA Tests
  • Immunodiagnostics
  • Others
  • Microbiology
  • Parasitology

By Pet Type

  • Dogs
  • Cats
  • Horses
  • Other Pet Animals
  • Birds
  • Small Mammals (Rabbits, etc.)
  • Exotic Pets (Reptiles and Amphibians)

By End User

  • Veterinary Clinics
  • Veterinary Hospitals
  • Research Laboratories
  • Home Care Settings
  • Diagnostics Centres
In 2023, the consumables segment commands half of the Japan Pet Diagnostics Market, driven by increased veterinary test frequency and spending. This growth is supported by rising animal disease prevalence, higher disposable incomes, and substantial investments in advanced diagnostic kits. Veterinary care ranks as the second highest expense for pet owners in Japan, underscoring its importance after food expenditures (Allianz Global Investors, 2021). The consumables segment is anticipated to grow at a moderate CAGR of 7.34%, buoyed by expanding veterinary hospital numbers and ongoing research in companion and livestock health. By 2021, Japan boasted 12,435 animal hospitals, marking an 18% increase from a decade earlier, with Tokyo seeing a notable 26% rise to 1,816 facilities (Ministry of Agriculture, Forestry, and Fisheries).

The diagnostic imaging segment emerged dominant in the global veterinary diagnostics market in 2023. Widely adopted for its broad applications, including critical conditions like arboviral diseases, diagnostic imaging tools like MRI and CT scans enhance treatment outcomes. Similarly, the immunodiagnostics segment held a substantial global market share, providing rapid results crucial for timely treatment in veterinary clinics without extensive lab setups. For instance, Fujifilm Wako Pure Chemical Corporation's LabAssay Series facilitates efficient biochemical analysis of animal samples in microtiter plates.

In Japan, the Immunodiagnostics segment led with a 24% market share in 2023, essential for detecting diseases in companion and livestock animals, from infectious diseases (e.g., parvovirus, FIV) to cancer markers. This method is relatively cost-effective once infrastructure is established, enhancing accessibility in resource-limited settings. Conversely, Molecular Diagnostics is poised for the highest CAGR, driven by new tests targeting prevalent animal diseases like feline leukemia and canine parvovirus, supported by increased pet and livestock ownership and heightened health awareness.

The Dogs segment dominated the market with a 51% share in 2023, expected to grow due to rising pet insurance adoption, pet population, and trends in pet humanization and medicalization. Anicom Insurance Inc. offers extensive coverage for medical expenses at over 6,000 veterinary hospitals, supporting ongoing health needs like preventive care, disease screening, and treatment for dogs, susceptible to genetic, infectious, and age-related ailments.

The Veterinary Clinics segment holds the largest market share, with Veterinary Hospitals experiencing the fastest growth in Japan's Pet Diagnostics Market. The rise is fueled by increased animal healthcare spending and a surge in facilities nationwide, reflecting Japan's growing pet ownership (28.2% of the population), benefiting from enhanced care and longer lifespans. Equipped with advanced diagnostic tools like digital radiography and ultrasound, veterinary clinics ensure accurate evaluations and tailored treatment plans for animal health conditions.

Competitive Landscape:

The Pet Diagnostics market is characterized by a vigorous competitive landscape, with prominent entities like IDEXX, Fujifilm Holdings Corporation, ZoetisThermo Fisher Scientific Inc., Sysmex Corporation and Others at the forefront, collectively accounting for more than 45% of the overall market share. This competitive milieu is fueled by their intensive efforts in research and development as well as strategic partnerships and collaborations, underscoring their commitment to solidifying market presence and diversifying their offerings. The primary competitive factors include pricing, product caliber, and technological innovation. As the Pet Diagnostics industry continues to expand, the competitive fervor among these key players is anticipated to intensify. The impetus for ongoing innovation and alignment with evolving customer preferences and stringent regulations is high. The industry's fluidity anticipates an uptick in novel innovations and strategic growth tactics from these leading corporations, which in turn propels the sector's comprehensive growth and transformation.

Report Insights:

  • The Japan Pet Diagnostics market is projected to grow from US$ 0.17 Billion in 2023 to US$ 0.30 Billion by 2032, at a CAGR of 6.78%.
  • Diagnostic imaging and immunodiagnostics segments lead the market, driven by advanced technologies like MRI, CT scans, and rapid test kits.
  • Rising pet ownership and cultural shifts towards pet humanization are key drivers of market growth.
  • The market is characterized by prominent players such as IDEXX, Fujifilm Holdings Corporation, and Zoetis, collectively accounting for over 45% of the market share.

Questions to be Answered:

  • What is the estimated growth rate of the Pet Diagnostics market?
  • What are the key drivers and potential restraints?
  • Which market segments are expected to witness significant growth?
  • Who are the leading players in the market?

Table of Contents

Chapter 1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
Chapter 2. Research Methodology
2.1. Qualitative Research
2.1.1. Primary & Secondary Sources
2.2. Quantitative Research
2.2.1. Primary & Secondary Sources
2.3. Breakdown of Primary Research Respondents, By Region
2.4. Assumption for the Study
2.5. Market Size Estimation
2.6. Data Triangulation
Chapter 3. Executive Summary: Japan Pet Diagnostics Market
Chapter 4. Japan Pet Diagnostics Market Overview
4.1. Industry Value Chain Analysis
4.1.1. Material Provider
4.1.2. Manufacturer
4.1.3. Distributor / Service Provider
4.1.4. End User
4.2. Industry Outlook
4.2.1. Leading animal health companies in 2022, based on revenue worldwide
4.2.2. Overview of Evolving Trends in Japan's Pet diagnostics Market
4.3. PESTLE Analysis
4.4. Porter's Five Forces Analysis
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Power of Buyers
4.4.3. Threat of Substitutes
4.4.4. Threat of New Entrants
4.4.5. Degree of Competition
4.5. Market Dynamics and Trends
4.5.1. Growth Drivers
4.5.1.1. Increasing Pet adoption for companionship
4.5.2. Restraints
4.5.3. Challenges
4.5.4. Key Trends
4.6. COVID-19 Impact Assessment on Market Growth Trend
4.7. Market Growth and Outlook
4.7.1. Market Revenue Estimates and Forecast (US$ Mn), 2019-2032
4.8. Competition Dashboard
4.8.1. Market Concentration Rate
4.8.2. Company Market Share Analysis (Value %), 2023
4.8.3. Competitor Mapping
Chapter 5. Japan Pet Diagnostics Market Analysis, By Offerings
5.1. Key Insights
5.2. Market Size and Forecast, 2019-2032 (US$ Mn)
5.2.1. Instruments
5.2.1.1. Analysers
5.2.1.2. Imaging Equipment's
5.2.1.3. Hematology Instruments
5.2.1.4. Others
5.2.2. Consumables
5.2.2.1. Reagents
5.2.2.2. Test Kits
5.2.2.3. Strips
5.2.2.4. Others
5.2.3. Services
Chapter 6. Japan Pet Diagnostics Market Analysis, By Technique
6.1. Key Insights
6.2. Market Size and Forecast, 2019-2032 (US$ Mn)
6.2.1. Diagnostic Imaging
6.2.1.1. X-ray
6.2.1.2. Ultrasound
6.2.1.3. MRI
6.2.1.4. CT scan
6.2.2. Clinical Biochemistry
6.2.2.1. Blood tests
6.2.2.2. Urinalysis
6.2.3. Molecular Diagnostics
6.2.3.1. PCR
6.2.3.2. Microarrays
6.2.3.3. DNA Tests
6.2.4. Immunodiagnostics
6.2.4.1. ELISA
6.2.4.2. Rapid tests
6.2.4.3. Antibody Tests
6.2.5. Haematology
6.2.6. Others (Histopathology, Cytology)
Chapter 7. Japan Pet Diagnostics Market Analysis, By Application
7.1. Key Insights
7.2. Market Size and Forecast, 2019-2032 (US$ Mn)
7.2.1. Clinical Pathology
7.2.1.1. Haematology
7.2.1.2. Clinical chemistry
7.2.1.3. Immunodiagnostics
7.2.2. Pathology
7.2.2.1. Histopathology
7.2.2.2. Cytology
7.2.3. Molecular Diagnostics
7.2.3.1. Infectious diseases
7.2.3.2. Genetic disorders
7.2.3.3. DNA Tests
7.2.4. Immunodiagnostics
7.2.5. Others
7.2.5.1. Microbiology
7.2.5.2. Parasitology
Chapter 8. Japan Pet Diagnostics Market Analysis, By Pet Type
8.1. Key Insights
8.2. Market Size and Forecast, 2019-2032 (US$ Mn)
8.2.1. Dogs
8.2.2. Cats
8.2.3. Horses
8.2.4. Other Pet Animals
8.2.4.1. Birds
8.2.4.2. Small Mammals (Rabbits, etc.)
8.2.4.3. Exotic Pets (Reptiles and Amphibians)
Chapter 9. Japan Pet Diagnostics Market Analysis, By End-User
9.1. Key Insights
9.2. Market Size and Forecast, 2019-2032 (US$ Mn)
9.2.1. Veterinary Clinics
9.2.2. Veterinary Hospitals
9.2.3. Research Laboratories
9.2.4. Home Care Settings
9.2.5. Diagnostics Centres
Chapter 10. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)
10.1. Arkay Inc.
10.2. Bussan Animal Health Co., Ltd.
10.3. Fujifilms
10.4. FUJIHIRA INDUSTRY CO.,LTD.
10.5. Heska Corporation
10.6. IDEXX
10.7. Randox Laboratories Ltd.
10.8. Seamaty
10.9. Sysmex Corporation
10.10. SHIN NIPPON BIOMEDICAL LAB, LTD.
10.11. Thermo Fisher Scientific
10.12 Zoetis
10.13. Other Prominent Player

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Arkay Inc.
  • Bussan Animal Health Co., Ltd.
  • Fujifilms
  • FUJIHIRA INDUSTRY CO.,LTD.
  • Heska Corporation
  • IDEXX
  • Randox Laboratories Ltd.
  • Seamaty
  • Sysmex Corporation
  • SHIN NIPPON BIOMEDICAL LAB, LTD.
  • Thermo Fisher Scientific
  • Zoetis
  • Other Prominent Player

Table Information